IDiyas

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 11666542 B1

PDFFull Text
Date of Patent:
Jun. 06, 2023

Filed:

Jul. 18, 2017

Use of cannabidiol in treatment of pulmonary hypertension

Applicant:

Deyi Pharmarmaceutical Ltd., Kunming, CN;

Inventors:

Ke Zhang, Beijing, CN;

Xin Tan, Beijing, CN;

Zhaohui Yu, Beijing, CN;

Xiangdong Li, Beijing, CN;

Assignee:

DEYI PHARMARMACEUTICAL LTD., Kunming, CN;

Attorney:

Platinum Intellectual Property PC

Primary Examiner:

Michael V Meller

Int. Cl.
CPC ...
A61K 31/05 (2006.01); A61P 9/12 (2006.01); A61P 11/00 (2006.01); A61K 31/191 (2006.01); A61K 31/192 (2006.01); A61K 31/4985 (2006.01); A61K 31/506 (2006.01); A61K 31/519 (2006.01); A61K 31/53 (2006.01); A61K 36/185 (2006.01); A61K 45/06 (2006.01);
U.S. Cl.
CPC ...
A61K 31/05 (2013.01); A61K 31/191 (2013.01); A61K 31/192 (2013.01); A61K 31/4985 (2013.01); A61K 31/506 (2013.01); A61K 31/519 (2013.01); A61K 31/53 (2013.01); A61K 36/185 (2013.01); A61K 45/06 (2013.01); A61P 9/12 (2018.01); A61P 11/00 (2018.01);
Abstract

The present invention belongs to the field of medicine, and relates to use of cannabidiol (CBD) in the treatment of pulmonary arterial hypertension. The CBD can be used as the only active ingredient or combined with other active ingredients to prepare a medicament for treating pulmonary arterial hypertension. Specifically, the present invention relates to use of any one selected from (1) to (3) in the preparation of a medicament for treating and/or preventing pulmonary arterial hypertension: (1) CBD, (2) a plant extract containing the CBD; and preferably, the plant extract is a cannabis extract, and (3) a pharmaceutical composition containing the CBD and one or more pharmaceutically acceptable adjuvants. In the present invention, upon experimental researches, it has found that the CBD has the function of inhibiting pulmonary arterial hypertension, and is especially suitable for treating the pulmonary arterial hypertension caused by hypoxemia.

Find Patent Forward Citations

Loading…